| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.17▼ | 1.17▼ | 1.17▼ | 1.21▼ | 1.25▼ |
| MA10 | 1.18▼ | 1.19▼ | 1.20▼ | 1.28▼ | 1.51▼ |
| MA20 | 1.22▼ | 1.23▼ | 1.23▼ | 1.23▼ | 2.58▼ |
| MA50 | 1.25▼ | 1.30▼ | 1.28▼ | 1.58▼ | 5.51▼ |
| MA100 | 1.31▼ | 1.25▼ | 1.31▼ | 2.72▼ | 18.10▼ |
| MA200 | 1.33▼ | 1.52▼ | 1.71▼ | 4.21▼ | 47.05▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.006▼ | -0.006▼ | -0.009▼ | 0.027▲ | 0.126▲ |
| RSI | 39.798▼ | 39.469▼ | 39.242▼ | 37.547▼ | 30.876▼ |
| STOCH | 20.492 | 16.997▼ | 14.802▼ | 22.153 | 14.137▼ |
| WILL %R | -76.923▼ | -80.000▼ | -81.250▼ | -89.091▼ | -93.030▼ |
| CCI | -84.871 | -87.265 | -91.386 | -91.708 | -77.952 |
|
Wednesday, November 19, 2025 05:31 AM
MIRAMAR, Fla., Nov. 19, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (HCWB), a U.S.-based clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies to ...
|
|
Tuesday, November 18, 2025 04:25 AM
Active component of HCW9302 is interleukin-2 -- cytokine that maintains proper numbers and functions of regulatory T cells to control excessive inflammation Gateway to development of a first-in-kind ...
|
|
Monday, November 17, 2025 11:25 PM
First Patient Dosed at The Ohio State UniversityWexner Medical Center in this Multi-Center Trial Active component of HCW9302 is interleukin-2 -- cytokine that maintains proper numbers and functions of ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 30/01/26 | 1.16 | 1.16 | 1.16 | 1.16 | 36,538 |
| 29/01/26 | 1.2427 | 1.267 | 1.12 | 1.14 | 69,340 |
| 28/01/26 | 1.26 | 1.3184 | 1.21 | 1.22 | 40,505 |
| 27/01/26 | 1.28 | 1.32 | 1.23 | 1.275 | 40,513 |
| 26/01/26 | 1.35 | 1.36 | 1.19 | 1.24 | 135,869 |
| 23/01/26 | 1.41 | 1.4593 | 1.29 | 1.35 | 92,834 |
| 22/01/26 | 1.2947 | 1.65 | 1.2947 | 1.39 | 112,883 |
| 21/01/26 | 1.3606 | 1.3895 | 1.2501 | 1.33 | 59,434 |
| 20/01/26 | 1.35 | 1.44 | 1.30 | 1.35 | 74,296 |
| 16/01/26 | 1.1705 | 1.39 | 1.1705 | 1.38 | 232,676 |
|
|
||||
|
|
||||
|
|